reviewThe Lancet Diabetes & EndocrinologyJul 8, 2024GREEN OA

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

University Medical Center Groningen · University of Groningen · +39 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

No related works found for this paper.

Funding